| # | Drug | Count |
|---|---|---|
| 0 | COPPER | 10 |
| 1 | ADALIMUMAB | 3 |
| 2 | LEVONORGESTREL | 3 |
| 3 | INFLIXIMAB | 2 |
| 4 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 |
| 5 | ADALIMUMAB-AATY | 1 |
| 6 | ADALIMUMAB-ADAZ | 1 |
| 7 | ADALIMUMAB-FKJP | 1 |
| 8 | ALEMTUZUMAB | 1 |
| 9 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELAGOLIX | 1 | 0.0003 |
| 1 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 1 | 0.0002 |
| 2 | COPPER | 10 | 0.0002 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 4 | ALEMTUZUMAB | 1 | 0.0001 |
| 5 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 6 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 7 | ADALIMUMAB-ADAZ | 1 | 0.0000 |
| 8 | LEVONORGESTREL | 3 | 0.0000 |
| 9 | INFLIXIMAB | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 10 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Progestin [EPC] | 3 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Interferon beta [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 3 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 | 0.0000 |